Reactivating potency of obidoxime, pralidoxime, HI 6 and HLo 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds

Archives of Toxicology

Volumn 72, Issue 4, 1998, Pages 237-243

  Worek, F ^a   Widmann, R ^a   Knopff, O ^a   Szinicz, L ^a  

^a Inst fur Pharmakol und Toxikol   (Germany)

Author keywords

Acetylcholinesterase; Organophosphates; Oxime; Reactivation

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; 1 [2,4 BIS(HYDROXYIMINOMETHYL)PYRIDINIO] 1' (4 CARBAMOYLPYRIDINIO)DIMETHYL ETHER DIIODIDE; ACETYLCHOLINESTERASE; OBIDOXIME; ORGANOPHOSPHATE; ORGANOPHOSPHORUS COMPOUND; PRALIDOXIME; SARIN; SOMAN; TABUN;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME REACTIVATION; ERYTHROCYTE; HUMAN; HUMAN CELL; INTOXICATION; PRIORITY JOURNAL;

ACETYLCHOLINESTERASE; ANTIDOTES; CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; ERYTHROCYTES; HUMANS; OBIDOXIME CHLORIDE; PHOSPHORIC ACID ESTERS; PRALIDOXIME COMPOUNDS; PYRIDINES; PYRIDINIUM COMPOUNDS; SOMAN;

ANIMALIA;

EID: 0031978963     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040050495     Document Type: Article

References (45)

1. Adler M, Maxwell DM, Filbert MG, Deshpande SS (1994) Contribution of direct actions of the oxime HI-6 in reversing soman-induced muscle weakness in the rat diaphragm. Eur J Pharmacol 270: 9-16
2. Ballantyne B, Marrs TC (1992) Overview of the biological and clinical aspects of organophosphates and carbamates. In: Ballantyne B, Marrs TC (eds) Clinical and experimental toxicology of organophosphates and carbamates. Butterworth/Heinemann, Oxford, pp 3-14
3. Berry WK, Davies DR (1966) Factors influencing the rate of 'aging' in a series of alkyl methylphosphonyl-acetylcholinesterases. Biochem J 100: 572-576
4. Bismuth C, Inns RH, Marrs TC (1992) Efficacy, toxicity and clinical use of oximes in anticholinesterase poisoning. In: Ballantyne B, Marrs TC (eds) Clinical and experimental toxicology of organophosphates and carbamates. Butterworth/Heinemann, Oxford, pp 555-577
5. Clement JG (1992) Efficacy of various oximes against GF (cyclohexylmethylphosphonofluoridate) poisoning in mice. Arch Toxicol 66: 143-144
6. Clement JG, Erhardt N (1994) In vitro oxime-induced reactivation of various molecular forms of soman-inhibited acetylcholinesterase in striated muscle from rat, monkey and human. Arch Toxicol 68: 648-655
7. Clement JG, Hansen AS, Boulet CA (1992) Efficacy of HLö-7 and pyrimidoxime as antidotes of nerve agent poisoning in mice. Arch Toxicol 66: 216-219
8. Clement JG, Bailey DG, Madill HD, Tran LT, Spence JD (1995) The acetylcholinesterase oxime reactivator HI-6 in man: pharmacokinetics and tolerability in combination with atropine. Biopharm Drug Dispos 16: 415-425
9. Coleman IW (1968) Cholinolytics in the treatment of anticholinesterase poisoning. V. The effectiveness of Parpanit with oximes in the treatment of organophosphorus poisoning. Can J Physiol Pharmacol 46: 106-117
10. Johnson MK, Vale JA (1992) Clinical management of acute organophosphate poisoning: an overview. In: Ballantyne B, Marrs TC (eds) Clinical and experimental toxicology of organophosphates and carbamates. Butterworth/Heinemann, Oxford, pp 528-535
11. de Jong LPA, Wolring GZ (1978) Effect of 1-(ar)-alkyl-hydroxyiminomethyl-pyridinium salts on reactivation and aging of acetylcholinesterase inhibited by ethyldimethylphosphoramidocyanidate (tabun). Biochem Pharmacol 27: 2229-2235
12. de Jong LPA, Wolring GZ (1984) Stereospecific reactivation by some Hagedorn-oximes of acetycholinesterases from various species including man inhibited by soman. Biochem Pharmacol 33: 1119-1125
13. de Jong LPA, Wolring GZ, Benschop HP (1982) Reactivation of acetylcholinesterase inhibited by methamidophos and analogous (di)methylphosphoramidates. Arch Toxicol 49: 175-183
14. de Jong LPA, Verhagen AAV, Langenberg JP, Hagedorn I, Löffler M (1989) The bispyridinium-dioxime HLö-7: a potent reactivator for acetylcholinesterase inhibited by the stereoisomers of tabun and soman. Biochem Pharmacol 38: 633-640
15. Ellman GL, Courtney KD, Anders V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88-95
16. Erdmann WD, Bosse I, Franke P (1965) Zur Resorption und Ausscheidung von Toxogonin nach intramuskulärer Injektion am Menschen. Dtsch Med Wochenschr 90: 1436-1438
17. Eyer P, Hagedorn I, Klimmek R, Lippstreu P, Löffler M, Oldiges H, Spöhrer U, Steidl I, Szinicz L, Worek F (1992) HLö 7 dimethanesulfonate, a potent bispyridinium-dioxime against anticholinesterases. Arch Toxicol 66: 603-621
18. Fleisher JH, Harris LW, Murtha EF (1967) Reactivation by pyridinium aldoxime methochloride (PAM) of inhibited cholinesterase activity in dogs after poisoning with pinacolyl methylphosphonofluoridate (soman). J Pharmacol Exp Ther 156: 345-351
19. Grubic Z, Tomazic A (1989) Mechanism of action of HI-6 on soman inhibition of acetylcholinesterase in preparations of rat and human skeletal muscle; comparison to SAD-128 and PAM-2. Arch Toxicol 63: 68-71
20. Harris LW, Heyl WC, Stitcher DL, Broomfield CA (1978) Effects of 1,1′-oxydimethylene bis-(4-tert-butylpyridinium chloride) (SAD-128) and decamethonium on reactivation of soman-and sarin-inhibited cholinesterase by oximes. Biochem Pharmacol 27: 757-761
21. Heilbronn E (1963) In vitro reactivation and "ageing" of tabun-inhibited blood cholinesterase. Biochem Pharmacol 12: 25-36
22. Jokanovic M, Maksimovic M, Kilibarda V, Jovanovic D, Savic D (1996) Oxime-induced reactivation of acetylcholinesterase inhibited by phosphoramidates. Toxicol Lett 85: 35-39
23. Kassa J, Bajgar J (1995) Comparison of the efficacy of HI-6 and obidoxime against cyclohexyl melhyl-phosphonofluoridate (GF) in rats. Hum Exp Toxicol 14: 923-928
24. Koplovitz I, Gresham VC, Dochterman LW, Kaminskis A, Stewart JR (1992) Evaluation of the toxicity, pathology and treatment of cyclohexylmethylphosphonofluoridate (CMPF) poisoning in rhesus monkeys. Arch Toxicol 66: 622-628
25. Kusic R, Boskovic B, Vojvodic V, Jovanovic D (1985) HI-6 in man: blood levels, urinary excretion and tolerance after intramuscular administration of the oxime to healthy volunteers. Fundam Appl Toxicol 5: S89-S97
26. Lundy PM, Hansen AS, Hand BT, Boulet CA (1992) Comparison of several oximes against poisoning by soman, tabun and GF. Toxicology 72: 99-105
27. Melchers BPC, van der Laaken AL, Van Helden HPM (1991) On the mechanism whereby HI-6 improves neuromuscular function after oxime-resistant acetylcholinesterase inhibition and subsequent impairment of neuromuscular transmission. Eur J Pharmacol 200: 331-337
28. Nozaki H, Aikawa N, Fujishima S, Suzuki M, Shinozawa Y, Hori S, Nogawa S (1995) A case of VX poisoning and the difference from sarin. Lancet 346: 698-699
29. Okumura T, Takasu N, Ishimatsu S, Miyanoki S, Mitsuhashi A, Kumuda K, Tanaka K, Hinohara S (1996) Report of 640 victims of the Tokyo subway sarin attack. Ann Emerg Med 28: 129-135
30. Puu G, Artursson E, Bucht G (1986) Reactivation of nerve agent inhibited human acetylcholinesterases by HI-6 and obidoxime. Biochem Pharmacol 35: 1505-1510
31. Rousseaux CG, Dua AK (1989) Pharmacology of HI-6, an H-series oxime. Can J Physiol Pharmacol 67: 1183-1189
32. Sachs L (1974) Angewandte Statistik. Springer, Berlin
33. Sidell FR, Groff WA (1970) Toxogonin: blood levels and side effects after intramuscular administration in man. J Pharmacol Sci 59: 793-797
34. Sidell FR, Groff WA (1971) Intramuscular and intravenous administration of small doses of 2-pyridinium aldoxime methochloride to man. J Pharmacol Sci 60: 1224-1228
35. Sidell FR, Groff WA (1974) The reactivatibility of cholinesterase inhibited by VX and sarin in man. Toxicol Appl Pharmacol 27: 241-252
36. Skrinjaric-Spoljar M, Kralj M (1980) Reactivating and protective effects of pyridinium compounds in human erythrocyte acetylcholinesterase inhibition by organophosphates in vitro. Arch Toxicol 45: 21-27
37. Smith AP, Van Der Wiel HJ, Wolthuis OL (1981) Analysis of oxime-induced neuromuscular recovery in guinea pig, rat and man following soman poisoning in vitro. Eur J Pharmacol 70: 371-379
38. Spöhrer U, Thiermann H, Klimmek R, Eyer P (1994) Pharmacokinetics of the oximes HI 6 and HLö 7 in dogs after i.m. injection with newly developed dry/wet autoinjectors. Arch Toxicol 68: 480-489
39. Sun MC, Li FZ, Chou TC (1986) Reactivation of sarin-or somanphosphonylated human acetylcholinesterase by bis-pyridinium mono-oximes. Biochem Pharmacol 35: 347-349
40. Suzuki T, Morita H, Ono K, Maekawa K, Nagai R, Yazaki Y (1995) Sarin poisoning in Tokyo subway. Lancet 345: 980
41. Talbot BG, Anderson DR, Harris LW, Yarbrough LW, Lennox WJ (1988) A comparison of in vivo and in vitro rates of aging of soman-inhibited erythrocyte acetylcholinesterase in different animal species. Drug Chem Toxicol 11: 289-305
42. Van Helden HPM, Busker RW, Melchers BPC, Bruijnzel PLB (1996) Pharmacological effects of oximes: how relevant are they? Arch Toxicol 70: 779-786
43. Wolthuis OL, Vanwersch RAP, Van Der Wiel HJ (1981) The efficacy of some bis-pyridinium oximes as antidotes to soman in isolated muscles of several species including man. Eur J Pharmacol 70: 355-369
44. Worek F, Kirchner T, Bäcker M, Szinicz L (1996) Reactivation by various oximes of human erythrocyte acetylcholinesterase inhibited by different organophosphorus compounds. Arch Toxicol 70: 497-503
45. Worek F, Bäcker M, Thiermann H, Szinicz L, Mast U, Klimmek R, Eyer P (1997) Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Hum Exp Toxicol 16: 466-472